Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer

This publication has 37 references indexed in Scilit:

• Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer
  Current Opinion in Oncology, 2011
• Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis
  Journal of Clinical Oncology, 2010
• Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
  Annals of Oncology, 2010
• Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications
  Radiotherapy and Oncology, 2010
• Critical Review of Nonsurgical Treatment Options for Stage I Non-Small Cell Lung Cancer
  The Oncologist, 2008
• Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer
  International Journal of Radiation Oncology*Biology*Physics, 2008
• Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study
  Journal of Thoracic Oncology, 2007
• Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer
  Journal of Clinical Oncology, 2006
• American Society for Therapeutic Radiology and Oncology* and American College of Radiology Practice Guideline for the Performance of Stereotactic Body Radiation Therapy
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Global cancer statistics in the year 2000
  The Lancet Oncology, 2001